• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].

作者信息

Saugstad O D, Danielsen K, Grønn M, Holt J, Meberg A, Silberg I E, Okland O

机构信息

Pediatrisk forskningsinstitutt, Rikshospitalet, Oslo.

出版信息

Tidsskr Nor Laegeforen. 1993 Aug 20;113(19):2389-93.

PMID:8378900
Abstract

43 Norwegian premature infants with respiratory distress syndrome were randomized to receive either a high dose (initial dose 200 mg/kg) or a low dose (initial dose 100 mg/kg) of natural porcine surfactant (Curosurf). In the high dose group, up to five doses of surfactant could be given compared with three in the low dose group. In the high dose group, oxygen requirement was significantly lower during the first 36 hours after surfactant was administered than the requirement in the low dose group. There was no difference in outcome between the high and low dose groups. Outcome was poor for babies with birthweight < 750 gram or gestational age < 26 weeks, in spite of an initial favourable surfactant response in several of them. We conclude that the initial dose of Curosurf should be 100 mg/kg and two more doses can be given if necessary.

摘要

相似文献

1
[Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
Tidsskr Nor Laegeforen. 1993 Aug 20;113(19):2389-93.
2
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.欧洲关于严重新生儿呼吸窘迫综合征表面活性剂替代疗法的多中心随机试验:单剂量与多剂量珂立苏对比研究
Pediatrics. 1992 Jan;89(1):13-20.
3
Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?对于早产儿呼吸窘迫综合征,是否有必要多次使用表面活性剂?
Turk J Pediatr. 2012 Jul-Aug;54(4):368-75.
4
[Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome].[两种不同剂量猪肺表面活性物质对重度呼吸窘迫综合征早产儿肺气体交换的影响]
Monatsschr Kinderheilkd. 1993 Sep;141(9):721-7.
5
[Natural surfactant in routine treatment of neonatal respiratory distress syndrome. Experiences from two central hospitals].[天然表面活性剂在新生儿呼吸窘迫综合征常规治疗中的应用。两家中心医院的经验]
Tidsskr Nor Laegeforen. 1997 Apr 20;117(10):1453-6.
6
[Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].[使用气管内给药表面活性剂预防和治疗早产儿呼吸窘迫综合征]
Ned Tijdschr Geneeskd. 1992 Oct 10;136(41):2018-24.
7
Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.比较天然表面活性剂肺泡表面活性物质(Alveofact)和珂立苏(Curosurf)治疗早产儿呼吸窘迫综合征临床疗效的观察性研究。
Respir Med. 2007 Jan;101(1):169-76. doi: 10.1016/j.rmed.2006.03.033. Epub 2006 May 15.
8
[Treatment of severe respiratory distress syndrome with surfactant].[用表面活性剂治疗严重呼吸窘迫综合征]
Ugeskr Laeger. 1992 Jun 1;154(23):1642-5.
9
Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.表面活性剂用于预防自主呼吸的新生儿呼吸窘迫综合征。一项随机多中心临床试点研究。
Acta Biomed Ateneo Parmense. 1997;68 Suppl 1:39-45.
10
[Surfactant treatment of premature infants with respiratory distress syndrome].
Tidsskr Nor Laegeforen. 1990 Nov 30;110(29):3737-41.